Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Buildings (2016 - 2019)

Myriad Genetics (MYGN) has disclosed Buildings for 5 consecutive years, with $18.2 million as the latest value for Q3 2019.

  • Quarterly Buildings fell 3.7% to $18.2 million in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $18.2 million through Sep 2019, down 3.7% year-over-year, with the annual reading at $18.8 million for FY2019, 2.59% down from the prior year.
  • Buildings for Q3 2019 was $18.2 million at Myriad Genetics, down from $18.8 million in the prior quarter.
  • The five-year high for Buildings was $20.5 million in Q1 2018, with the low at $16.1 million in Q4 2016.
  • Average Buildings over 5 years is $18.2 million, with a median of $18.2 million recorded in 2015.
  • The sharpest move saw Buildings dropped 13.3% in 2017, then increased 25.77% in 2018.
  • Over 5 years, Buildings stood at $17.3 million in 2015, then fell by 6.94% to $16.1 million in 2016, then rose by 22.98% to $19.8 million in 2017, then fell by 4.55% to $18.9 million in 2018, then fell by 3.7% to $18.2 million in 2019.
  • According to Business Quant data, Buildings over the past three periods came in at $18.2 million, $18.8 million, and $18.6 million for Q3 2019, Q2 2019, and Q1 2019 respectively.